EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolomic Analysis of Breast Cancer in Colombian Patients: Exploring Molecular Signatures in Different Subtypes and Stages

Lizeth León-Carreño, Daniel Pardo-Rodriguez iD, Andrea Del Pilar Hernandez-Rodriguez iD, Juliana Ramírez-Prieto, Gabriela López-Molina iD, Ana G Claros iD, Daniela Cortes-Guerra, Julian Alberto-Camargo, Wilson Rubiano-Forero, Adrian Sandoval-Hernandez iD, Mónica P Cala iD, Alejandro Ondo-Mendez iD

International Journal of Molecular Sciences · 26.07.2025 · 26 (15) · 7230

DOI: 10.3390/ijms26157230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.07.2025. Verfasst von Lizeth León-Carreño und 11 weiteren Autor:innen. Beteiligte Einrichtung: Metabolomics Core Facility-MetCore, Vice-Presidency for Research, Universidad de los Andes, Bogotá 110111, Colombia. Hauptthemen laut MEDLINE: Breast Neoplasms, Metabolomics, Metabolome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Universitario Mayor, Mederi, Ministerio de Ciencia, Tecnología e Innovación, Center for Research of the Hospital Universitario Mayor-Méderi (CIMED).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer (BC) is a neoplasm characterized by high heterogeneity and is influenced by intrinsic molecular subtypes and clinical stage, aspects that remain underexplored in the Colombian population. This study aimed to characterize metabolic alterations associated with subtypes and disease progression in a group of newly diagnosed, treatment-naive Colombian women using an untargeted metabolomics approach. To improve metabolite coverage, samples were analyzed using LC-QTOF-MS and GC-QTOF-MS, along with amino acid profiling. The Luminal B subtype exhibited elevated levels of long-chain acylcarnitines and higher free fatty acid concentrations than the other subtypes. It also presented elevated levels of carbohydrates and essential glycolytic intermediates, suggesting that this subtype may adopt a hybrid metabolic phenotype characterized by increased glycolytic flux as well as enhanced fatty acid catabolism. Tumor, Node, and Metastasis (TNM) staging analysis revealed progressive metabolic reprogramming of BC. In advanced stages, a sustained increase in phosphatidylcholines and a decrease in lysophosphatidylcholines were observed, reflecting lipid alterations associated with key roles in tumor progression. In early stages (I-II), plasma metabolites with high discriminatory power were identified, such as glutamic acid, ribose, and glycerol, which are associated with dysfunctions in energy and carbohydrate metabolism. These results highlight metabolomics as a promising tool for the early diagnosis, clinical follow-up, and molecular characterization of BC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMetabolomicsMetabolomeHumansFemaleColombiaMiddle AgedAdultNeoplasm StagingBiomarkers, TumorAged

Stichwörter der Autor:innen

amino acid metabolismbreast cancercancer stagescancer subtypesenergy metabolismmetabolomic analysismolecular signatures

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Metabolomics Core Facility-MetCore, Vice-Presidency for Research, Universidad de los Andes, Bogotá 110111, Colombia.
  • Clinical Research Group, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá 110011, Colombia.
  • Biochemistrry, Cancer and Radiobiology Research Incubator, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá 111221, Colombia.
  • Hospital Universitario Mayor-Méderi, Bogotá 110011, Colombia.
  • Grupo de Muerte Celular, Instituto de Genética, Universidad Nacional de Colombia-Sede Bogotá, Avenida Carrera 30, No. 45-03, Bogotá 110111, Colombia.

ORCID-Profile: Daniel Pardo-Rodriguez, Andrea Del Pilar Hernandez-Rodriguez, Gabriela López-Molina, Ana G Claros, Adrian Sandoval-Hernandez, Mónica P Cala, Alejandro Ondo-Mendez

Förderung

  • Hospital Universitario Mayor, Mederi
  • Ministerio de Ciencia, Tecnología e Innovación
  • Center for Research of the Hospital Universitario Mayor-Méderi (CIMED)
  • Young Researchers in Medicine Grant of the Colombian Ministry of Sciences and Technology (MinCiencias) and Pfizer

Zitieren

APA

León-Carreño, L., Pardo-Rodriguez, D., Hernandez-Rodriguez, A. D. P., Ramírez-Prieto, J., López-Molina, G., Claros, A. G., Cortes-Guerra, D., Alberto-Camargo, J., Rubiano-Forero, W., Sandoval-Hernandez, A., Cala, M. P., & Ondo-Mendez, A. (2025). Metabolomic Analysis of Breast Cancer in Colombian Patients: Exploring Molecular Signatures in Different Subtypes and Stages. International Journal of Molecular Sciences, 26(15), 7230. https://doi.org/10.3390/ijms26157230

Vancouver

León-Carreño L, Pardo-Rodriguez D, Hernandez-Rodriguez ADP, Ramírez-Prieto J, López-Molina G, Claros AG, et al. Metabolomic Analysis of Breast Cancer in Colombian Patients: Exploring Molecular Signatures in Different Subtypes and Stages. International Journal of Molecular Sciences. 2025;26(15):7230. doi:10.3390/ijms26157230

BibTeX
@article{LenCarreo2025,
  author = {León-Carreño, Lizeth and Pardo-Rodriguez, Daniel and Hernandez-Rodriguez, Andrea Del Pilar and Ramírez-Prieto, Juliana and López-Molina, Gabriela and Claros, Ana G and Cortes-Guerra, Daniela and Alberto-Camargo, Julian and Rubiano-Forero, Wilson and Sandoval-Hernandez, Adrian and Cala, Mónica P and Ondo-Mendez, Alejandro},
  title = {Metabolomic Analysis of Breast Cancer in Colombian Patients: Exploring Molecular Signatures in Different Subtypes and Stages},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {15},
  pages = {7230},
  doi = {10.3390/ijms26157230}
}
Kostenlos starten →